Type 1 diabetes

Metabolomic profile differs between latent autoimmune diabetes in adults (LADA) and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes

DiabetologiaPublished Cross-sectional study

Authors' conclusion

Metabolomic and lipidomic profiles differ between LADA and type 1 diabetes and vs RA, providing new insights into the heterogeneity of autoimmune diabetes. Our results confirm the involvement of tryptophan metabolism in autoimmune disorders, suggesting that the impaired activation of this pathway of immune tolerance in LADA is less pronounced than in type 1 diabetes, consistent with its milder degree of beta cell loss.

Study context

Population
Individuals with LADA, T1D or rheumatoid arthritis (RA) and healthy controls; plus pancreatic islets from healthy donors treated in vitro with proinflammatory cytokines
Participants
136 individuals
Exposure
LADA vs T1D vs RA vs healthy controls
  • LADAn = 49
  • T1Dn = 44
  • RAn = 29
  • Controln = 14reference
Outcome
Kyn/Trp ratio (marker of tryptophan pathway activation)
Methodological detailsmetabolomic and lipidomic analyses, in vitro pancreatic islet experiments
  • Metabolomic and lipidomic analyses
  • In vitro pancreatic islet experiments

Main finding

As reported in the abstract

Control

0.014

median · IQR 0.012–0.019

RA

0.027

median · IQR 0.022–0.032

LADA

0.021

median · IQR 0.018–0.024

T1D

0.018

median · IQR 0.014–0.022

ANCOVA p<0.0001

Observational data: associations, not effects.

Further findings

OutcomeP value
Association of Kyn/Trp with fasting C-peptide in LADALADA vs ControlP = 0.038

Lipidomic and metabolomic profiles

LADA and T1D differed from RA in lipidomics and metabolomics
Phosphatidylethanolamines, ceramides, lysophosphatidylcholine and several metabolites at TCA cycle entry sites higher in T1D vs LADA

Tryptophan concentration in pancreatic islets treated with proinflammatory cytokines

Tryptophan concentration reduced
80%

Original publication

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes. Diabetologia. Published 26 June 2026. doi:10.1007/s00125-026-06777-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.